Use of kinase inhibitors to dissect signaling pathways.
Cuenda
A
A
MRC Protein Phosphorylation Unit, University of Dundee, UK.
Alessi
D R
DR
D000730:Androstadienes / Q000737:chemistry; D000818:Animals; D002867:Chromones / Q000737:chemistry; D004791:Enzyme Inhibitors / Q000737:chemistry; D005419:Flavonoids / Q000737:chemistry; D006801:Humans; D007093:Imidazoles / Q000737:chemistry; D007211:Indoles / Q000737:chemistry; D008301:Maleimides / Q000737:chemistry; D009025:Morpholines / Q000737:chemistry; D047428:Protein Kinase Inhibitors; D011725:Pyridines / Q000737:chemistry; D015398:Signal Transduction; D020123:Sirolimus / Q000737:chemistry; D000077191:Wortmannin
D000730:Androstadienes; D002867:Chromones; D004791:Enzyme Inhibitors; D005419:Flavonoids; D007093:Imidazoles; D007211:Indoles; D008301:Maleimides; D009025:Morpholines; D047428:Protein Kinase Inhibitors; D011725:Pyridines; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; C070515:bisindolylmaleimide I; C093642:SB 203580; C090942:4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; D020123:Sirolimus; C064758:Ro 31-8220; D000077191:Wortmannin